LBR
Basic information
Region (hg38): 1:225401502-225428925
Links
Phenotypes
GenCC
Source:
- Greenberg dysplasia (Definitive), mode of inheritance: AR
- Pelger-Huet anomaly (Moderate), mode of inheritance: AD
- Greenberg dysplasia (Moderate), mode of inheritance: AR
- Greenberg dysplasia (Supportive), mode of inheritance: AR
- regressive spondylometaphyseal dysplasia (Supportive), mode of inheritance: AR
- Greenberg dysplasia (Strong), mode of inheritance: AR
- regressive spondylometaphyseal dysplasia (Strong), mode of inheritance: AR
- Pelger-Huet anomaly (Strong), mode of inheritance: AD
- Greenberg dysplasia (Moderate), mode of inheritance: AR
- regressive spondylometaphyseal dysplasia (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Reynolds syndrome; Pelger-Huet anomaly; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly; Greenberg dysplasia | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Hematologic; Musculoskeletal | 5553949; 3475111; 12118250; 14684694; 12618959; 20522425; 22338047 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (5 variants)
- RHIZOMELIC SKELETAL DYSPLASIA WITH PELGER-HUET ANOMALY (2 variants)
- Greenberg dysplasia (2 variants)
- Anadysplasia-like, spontaneously remitting spondylometaphyseal dysplasia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LBR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 46 | 52 | ||||
missense | 147 | 160 | ||||
nonsense | 2 | |||||
start loss | 1 | |||||
frameshift | 4 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 5 | 8 | 1 | 14 | ||
non coding | 20 | 36 | 27 | 83 | ||
Total | 7 | 5 | 172 | 88 | 33 |
Highest pathogenic variant AF is 0.0000329
Variants in LBR
This is a list of pathogenic ClinVar variants found in the LBR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-225401503-G-A | Greenberg dysplasia | Uncertain significance (Jan 13, 2018) | ||
1-225401534-T-A | Greenberg dysplasia | Uncertain significance (Jan 12, 2018) | ||
1-225401708-T-C | Greenberg dysplasia | Uncertain significance (Jan 13, 2018) | ||
1-225401717-C-T | Greenberg dysplasia | Uncertain significance (Jan 12, 2018) | ||
1-225401771-C-T | Greenberg dysplasia | Benign (Jan 13, 2018) | ||
1-225401805-A-G | Greenberg dysplasia | Uncertain significance (Jan 12, 2018) | ||
1-225401942-A-G | Greenberg dysplasia | Benign (Jan 13, 2018) | ||
1-225401998-G-C | Greenberg dysplasia | Uncertain significance (Jan 12, 2018) | ||
1-225402102-T-C | Greenberg dysplasia | Uncertain significance (Jan 12, 2018) | ||
1-225402103-A-G | Greenberg dysplasia | Uncertain significance (Jan 13, 2018) | ||
1-225402175-C-T | Greenberg dysplasia | Uncertain significance (Jan 12, 2018) | ||
1-225402254-G-C | Greenberg dysplasia | Uncertain significance (Jan 13, 2018) | ||
1-225402534-T-A | Greenberg dysplasia | Benign (Jan 13, 2018) | ||
1-225402617-T-C | Greenberg dysplasia | Uncertain significance (Jan 13, 2018) | ||
1-225402647-C-T | Greenberg dysplasia | Likely benign (Jan 12, 2018) | ||
1-225402679-A-T | Greenberg dysplasia | Uncertain significance (Jan 13, 2018) | ||
1-225402941-A-C | Greenberg dysplasia | Uncertain significance (Jan 12, 2018) | ||
1-225402973-A-C | Greenberg dysplasia | Benign (Jan 13, 2018) | ||
1-225403048-G-C | Greenberg dysplasia | Benign (Aug 19, 2018) | ||
1-225403270-G-C | Greenberg dysplasia | Uncertain significance (Jan 12, 2018) | ||
1-225403276-G-A | Greenberg dysplasia | Uncertain significance (Apr 27, 2017) | ||
1-225403313-T-C | Inborn genetic diseases | Uncertain significance (Sep 10, 2024) | ||
1-225403320-A-C | Uncertain significance (Mar 16, 2020) | |||
1-225403323-T-C | Greenberg dysplasia • Inborn genetic diseases | Uncertain significance (Apr 24, 2024) | ||
1-225403325-C-T | Uncertain significance (Feb 16, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LBR | protein_coding | protein_coding | ENST00000338179 | 13 | 27424 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.181 | 0.819 | 125732 | 0 | 16 | 125748 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.289 | 337 | 352 | 0.957 | 0.0000206 | 4000 |
Missense in Polyphen | 136 | 156.68 | 0.86803 | 1785 | ||
Synonymous | 1.19 | 110 | 127 | 0.866 | 0.00000725 | 1189 |
Loss of Function | 4.29 | 9 | 37.2 | 0.242 | 0.00000249 | 387 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000791 | 0.0000791 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Anchors the lamina and the heterochromatin to the inner nuclear membrane. {ECO:0000269|PubMed:10828963}.;
- Disease
- DISEASE: Pelger-Huet anomaly (PHA) [MIM:169400]: An autosomal dominant inherited abnormality of granulocytes, characterized by abnormal ovoid shape, reduced nuclear segmentation and an apparently looser chromatin structure. {ECO:0000269|PubMed:14617022}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Greenberg dysplasia (GRBGD) [MIM:215140]: A rare autosomal recessive chondrodystrophy characterized by early in utero lethality. Affected fetuses typically present with fetal hydrops, short-limbed dwarfism, and a marked disorganization of chondro-osseous calcification, and ectopic ossification centers. {ECO:0000269|PubMed:12618959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Reynolds syndrome (REYNS) [MIM:613471]: A syndrome specifically associating limited cutaneous systemic sclerosis and primary biliary cirrhosis. It is characterized by liver disease, telangiectasia, abrupt onset of digital paleness or cyanosis in response to cold exposure or stress (Raynaud phenomenon), and variable features of scleroderma. The liver disease is characterized by pruritis, jaundice, hepatomegaly, increased serum alkaline phosphatase and positive serum mitochondrial autoantibodies, all consistent with primary biliary cirrhosis. {ECO:0000269|PubMed:20522425}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
- Pathway
- Gastric Cancer Network 2;ATM Signaling Network in Development and Disease;Metabolism of lipids;zymosterol biosynthesis;Metabolism;cholesterol biosynthesis III (via desmosterol);cholesterol biosynthesis II (via 24,25-dihydrolanosterol);superpathway of cholesterol biosynthesis;Metabolism of steroids;cholesterol biosynthesis I;Cholesterol biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.291
Intolerance Scores
- loftool
- 0.0224
- rvis_EVS
- -0.71
- rvis_percentile_EVS
- 14.71
Haploinsufficiency Scores
- pHI
- 0.623
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.603
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.581
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lbr
- Phenotype
- immune system phenotype; renal/urinary system phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Gene ontology
- Biological process
- cholesterol biosynthetic process;sterol biosynthetic process;oxidation-reduction process
- Cellular component
- nuclear envelope;nuclear inner membrane;integral component of nuclear inner membrane;membrane;integral component of membrane;nuclear membrane
- Molecular function
- DNA binding;RNA binding;protein binding;lamin binding;delta14-sterol reductase activity;chromo shadow domain binding